SUN-122 Nuclear PDCD4 Expression Predicts Good Clinical Outcome in Luminal A-Like and Luminal B-Like Breast Cancer Subtypes

Hormone receptor-positive (HR+, estrogen and/or progesterone receptor-positive) and HER2-negative breast cancer (BC) subtype is a biologically heterogeneous entity that comprises 70% of BCs. This subtype includes both luminal (Lum) A- and B-like subtypes, which have differences in prognosis and sens...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Endocr Soc
Hlavní autoři: Madera, Santiago, Chiauzzi, Violeta A, Chervo, María F, Pereyra, Matías G, Venturutti, Leandro, Deamicis, Agustina Roldán, Dupont, Agustina, Guzmán, Pablo, Roa, Juan C, Cenciarini, Mauro E, Barchuk, Sabrina, Figurelli, Silvina, Vecchia, Daniel Lopez Della, Ares, Sandra, Proietti, Cecilia J, Deza, Ernesto Gil, Gercovich, Felipe G, Schillaci, Roxana, Elizalde, Patricia V, Cordo Russo, Rosalia I
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2020
Témata:
Tumor Biology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7208765/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.1037
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky